menu search

WST / West Pharmaceutical Services (WST) Q3 Earnings and Revenues Beat Estimates

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Beat Estimates
West Pharmaceutical Services (WST) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.03 per share a year ago. Read More
Posted: Oct 26 2023, 08:16
Author Name: Zacks Investment Research
Views: 112214

WST News  

West Pharmaceutical Services, Inc. (WST) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

West Pharmaceutical Services, Inc. (WST) Q3 2023 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET Company Participants Quintin Lai - Vice Pr more_horizontal

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Beat Estimates

By Zacks Investment Research
October 26, 2023

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Beat Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.86 per share. This more_horizontal

Medical equipment maker West Pharmaceutical raises 2023 profit forecast

By Reuters
October 26, 2023

Medical equipment maker West Pharmaceutical raises 2023 profit forecast

Medical equipment maker West Pharmaceutical Services on Thursday raised its 2023 adjusted profit forecast for a third time, benefiting from a stronger more_horizontal

What's in Store for West Pharmaceutical (WST) in Q3 Earnings?

By Zacks Investment Research
October 20, 2023

What's in Store for West Pharmaceutical (WST) in Q3 Earnings?

West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable curre more_horizontal

West Pharmaceutical Services: The Run Might Be Over

By Seeking Alpha
October 18, 2023

West Pharmaceutical Services: The Run Might Be Over

West Pharmaceutical Services, Inc. has experienced a 60% gain in its stock price so far in 2023 but has hit some recent technical headwinds. Insiders more_horizontal

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

By Zacks Investment Research
September 25, 2023

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist. more_horizontal

Which Is A Better Pick – Corning Stock Or West Pharmaceutical Services?

By Forbes
September 21, 2023

Which Is A Better Pick – Corning Stock Or West Pharmaceutical Services?

Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion. more_horizontal

Reasons to Retain West Pharmaceutical (WST) Stock for Now

By Zacks Investment Research
August 18, 2023

Reasons to Retain West Pharmaceutical (WST) Stock for Now

West Pharmaceutical's (WST) strength in its proprietary products segment raises optimism about the stock. more_horizontal


Search within

Pages Search Results: